— Know what they know.
Not Investment Advice
Also trades as: BAY.WA (WSE) · $vol 0M · BAYN.SW (SIX) · $vol 0M · BAYNN.MX (MEX) · $vol 0M

BAYRY OTC

Bayer AG
1W: -11.8% 1M: -11.2% 3M: -13.1% YTD: +14.0% 1Y: +45.3% 3Y: +6.1% 5Y: -2.5%
$12.64
-0.09 (-0.71%)
 
Weekly Expected Move ±4.5%
$12 $12 $13 $13 $14
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 32 · $49.7B mcap · 982M float · 0.097% daily turnover · Short 34% of daily vol
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$49.7B
52W Range7.48-15.23
Volume25,261
Avg Volume953,957
Beta0.83
Dividend$0.03
Analyst Ratings
1 Buy 2 Hold 0 Sell
Consensus Hold
Company Info
CEOBill Anderson
Employees88,078
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date1996-11-18
Websitebayer.com
Kaiser-Wilhelm-Allee 1
Leverkusen, NW 51368
DE
49 214 30 1
About Bayer AG

Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division concentrates on developing and marketing prescription medications, with key areas including cardiology and women's healthcare. It also offers specialized therapeutic solutions for oncology, hematology, and ophthalmology, alongside diagnostic imaging equipment, contrast agents, and advanced cell and gene therapies. Bayer's Consumer Health segment provides a wide array of non-prescription (over-the-counter) medicines, medical devices, medicated skincare items, and nutritional supplements. These self-care products address diverse health needs such as dermatology, dietary support, pain relief, cardiovascular risk prevention, digestive issues, allergy management, and cold and cough symptoms. The Crop Science division supports the agricultural sector with chemical and biological crop protection products, genetically enhanced plant traits, seeds, digital farming tools, and solutions for pest and weed control. This segment also manages the breeding, propagation, production, and specialized treatment of seeds, complemented by dedicated customer service for farmers. Bayer is actively involved in numerous strategic collaborations to bolster its research and development pipeline. These partnerships include an agreement with MD Anderson Cancer Center for oncology drug development, a research and licensing deal with Dewpoint Therapeutics, Inc. focused on novel treatments for cardiovascular and gynecological diseases, and collaborations with Exscientia Ltd, Foundation Medicine Inc., Evotec AG, and Arvinas Inc. Additionally, the company maintains strategic research alliances with the University of Oxford for gynecological therapies and with Kyoto University to discover potential new drugs for pulmonary conditions. The company’s products reach a broad market through various distribution channels, including wholesale partners, independent and chain pharmacies, supermarkets, online and other retail outlets, hospitals, and direct sales to agricultural producers. Bayer Aktiengesellschaft was established in 1863 and is headquartered in Leverkusen, Germany.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms